# How Smallpox Was Eradicated and What It Teaches Us

Surviving a modern infectious disease outbreak often feels like navigating an invisible minefield. During the height of the SARS-CoV-2 pandemic, a simple trip to the grocery store could evoke a primal, paralyzing anxiety—a terrifying game of survival roulette against an unseen respiratory pathogen. Yet, for all the profound disruption of the modern COVID-19 era, this contemporary anxiety is merely a faint echo of a biological terror that stalked humanity for over three millennia. Smallpox, an acute contagious disease caused by the variola virus, was a relentless specter that blinded, disfigured, and killed without prejudice [cite: 1]. The disease caused an estimated 300 million deaths in the twentieth century alone, with a staggering case fatality rate of up to 30% for natural infections [cite: 1, 2, 3]. Today, however, the variola virus exists only in highly secured laboratory freezers and the annals of medical history [cite: 1, 4]. 

How was this ancient scourge ultimately defeated? The direct answer is that smallpox was beaten not merely by the invention of a biological silver bullet, but through the execution of an unprecedented, decentralized global public health coalition. The campaign succeeded by pivoting away from naive mass-vaccination targets and instead implementing relentless on-the-ground epidemiological surveillance, highly localized "ring vaccination" containment strategies, and rigorous cross-cultural cooperation that transcended the deepest geopolitical divides of the Cold War [cite: 5, 6]. 

The primary lesson that this monumental achievement offers for modern epidemiology is that technological and medical solutions—no matter how advanced—cannot vanquish a pathogen in a vacuum. Disease eradication is fundamentally a social endeavor. It requires deep community trust, adaptable last-mile logistics, and the humility to tailor public health interventions to the specific cultural and infrastructural realities of the populations they are meant to protect [cite: 7, 8]. 

## Where Did the Pursuit of Immunity Begin? The Global Origins of Inoculation

The narrative of smallpox prevention is frequently, and inaccurately, condensed into a Eurocentric tale starring a single English physician at the end of the eighteenth century. In reality, the pursuit of immunity is a truly global story, deeply rooted in indigenous medical practices across Asia, Africa, and the Middle East long before the concept of modern vaccinology was formalized in the West [cite: 9, 10, 11].

Centuries before the development of the cowpox-derived smallpox vaccine, societies across the globe utilized a method known as variolation (or inoculation) [cite: 10, 11, 12]. Variolation involved deliberately infecting a healthy individual with infectious biological material drawn from the pustules, vesicles, or dried scabs of a patient suffering from a mild case of smallpox (variola minor) [cite: 9, 11, 13]. The goal was to induce a localized, manageable infection that would confer lifelong immunity against the far more lethal variola major [cite: 10]. Historical records and medical texts indicate that variolation was well known in China by the year 1500, where practitioners commonly inserted dried, pulverized smallpox scabs directly into the recipient's nostrils [cite: 10]. Similarly, ancient texts from India describe highly localized inoculation practices that integrated spiritual and medical healing [cite: 10]. 

Some of the most robust and detailed historical accounts of variolation, however, emanate from the African continent. In sub-Saharan Africa, variolation was a widely reported indigenous practice among various ethnic groups before, during, and after the colonial era [cite: 12, 13]. Among the Boran and Gabra pastoralists of northern Kenya and southern Ethiopia, traditional healers possessed sophisticated knowledge of infectious transmission [cite: 13]. Their technique consisted of scraping infective material from active smallpox vesicles into the skin on the dorsum of the lower forearm, intentionally triggering an immune response [cite: 13]. 

In North Africa, Arab populations utilized highly specific surgical methods that predate European vaccination by centuries. Detailed accounts from Cassem Algaida Aga, the ambassador from Tripoli in the eighteenth century, described a technique used extensively in the kingdoms of Tripoli, Tunis, and Algier [cite: 14]. A specialized surgeon would make a small incision between the thumb and forefinger to insert mature smallpox matter [cite: 14]. The wound was carefully wrapped in a handkerchief to protect it from the air, and the patient was closely monitored as a mild fever and a limited number of pustules developed over subsequent days [cite: 14]. This practice was considered ancient and was heavily utilized by both urban inhabitants and nomadic "wild Arabs" to dramatically reduce the mortality rate of the disease [cite: 14]. 

The introduction of variolation to North America was directly facilitated by the knowledge of enslaved Africans. In 1721, the smallpox virus spread rapidly through Boston, ultimately infecting nearly half of the city's 11,000 inhabitants and claiming hundreds of lives [cite: 9]. During this devastating epidemic, the Puritan minister Cotton Mather championed a mass inoculation campaign [cite: 9, 10]. Mather had learned of the procedure not from European medical texts, but from his enslaved servant, Onesimus, a Guramante man from the region of modern-day southern Libya [cite: 9, 14]. Onesimus detailed how he had undergone an operation in Africa that gave him "something of the smallpox" to preserve him from the disease forever, displaying a prominent scar on his arm as proof of the procedure's efficacy [cite: 14]. This indigenous African knowledge initiated one of the first known public inoculation campaigns in American history [cite: 9].

While variolation drastically reduced the mortality rate to roughly 2%—compared to the 30% case fatality rate of naturally acquired smallpox—it carried severe epidemiological risks [cite: 11, 14]. Variolated individuals often developed severe secondary conditions, and more critically, they remained highly contagious while shedding the virus [cite: 11, 13]. Without strict quarantine, a variolated person could unintentionally spark a full-scale epidemic, making the practice a double-edged sword [cite: 11, 13]. 

The paradigm shifted fundamentally in 1796 when Edward Jenner, an English physician, observed that milkmaids who contracted cowpox—a milder disease caused by an orthopoxvirus closely related to variola—seemed completely immune to smallpox [cite: 1, 11, 15]. Jenner hypothesized that the animal virus could confer cross-immunity in humans. To test this, he transferred material from a cowpox sore on a milkmaid named Sarah Nelmes into the arm of an eight-year-old boy, James Phipps [cite: 15]. After Phipps recovered from the mild cowpox infection, Jenner deliberately exposed him to smallpox, and the boy did not fall ill [cite: 15, 16]. Because the Latin word for cow is *vacca*, this revolutionary procedure was termed "vaccination" [cite: 11]. It marked the first time a relatively safe, non-epidemic-inducing biological agent was used to prevent a deadly human disease [cite: 1, 2, 11].

## How Do Vaccines Work? The "Training Dummy" vs. "Secure Blueprint" Analogy

To fully appreciate the medical triumph of smallpox eradication and its relevance to contemporary epidemiology, it is crucial to understand how early vaccines functioned and how they fundamentally differ from the cutting-edge technologies deployed against modern pandemics, such as COVID-19. A clear real-world analogy helps demystify these complex immunological mechanisms: imagine the human immune system as an elite, highly reactive security force defending a walled compound.

The earliest forms of immunization, including variolation and the cowpox vaccine, operated on a principle of physical introduction. Variolation was akin to releasing a mildly armed, slightly weakened intruder directly into the compound [cite: 11, 17]. The security force (the immune system) fought off this manageable threat, learning its hand-to-hand combat tactics and memorizing its uniform so that if a fully armed army (natural variola major) attacked later, the guards would immediately recognize and neutralize it [cite: 2, 11, 17]. However, if the guards were immunocompromised or caught off guard, the mildly armed intruder could still cause immense damage [cite: 11, 13].

Jenner’s cowpox vaccine, and the subsequent live-attenuated viral vaccines pioneered by scientists like Louis Pasteur in the 19th century, refined this biological process [cite: 2, 17]. Instead of an armed intruder, these vaccines introduced a "training dummy"—a harmless lookalike [cite: 2]. The cowpox virus was structurally similar enough to smallpox that the immune system learned the precise physical shape of the enemy, but because cowpox was an animal virus poorly adapted to human replication, it could not cause severe disease [cite: 2, 15]. The security force battered the training dummy, produced specific pathogen-targeting antibodies, and created a permanent immunological memory [cite: 18, 19]. This strategy of using live but weakened (attenuated) pathogens, or harmless animal viruses, became the cornerstone of twentieth-century vaccinology, ultimately leading to the eradication of smallpox and near-eradication of polio [cite: 2, 17, 20].

Fast forward to the twenty-first century. As the world confronted the SARS-CoV-2 pandemic, scientists realized that cultivating massive quantities of live viruses to create physical training dummies was a slow, complex, and occasionally risky bio-manufacturing process [cite: 17, 20]. This challenge ushered in the fifth era of vaccinology: messenger RNA (mRNA) technology, representing a staggering paradigm shift in how we prime the human immune system [cite: 2, 18]. 

If early vaccines relied on introducing a physical training dummy, mRNA vaccines act as a secure, self-destructing USB drive containing a digital instruction blueprint [cite: 19, 20].

[image delta #1, 0 bytes]

 The foundational breakthrough occurred in 2008 when Katalin Karikó and Drew Weissman modified mRNA using nucleoside analogues, stabilizing the fragile molecule and eliminating its capacity to induce an unwanted innate inflammatory response [cite: 2]. When an individual receives an mRNA vaccine today, no virus—live, dead, or attenuated—is injected into the body [cite: 2, 19]. Instead, the vaccine consists of a strand of synthetic mRNA (the blueprint) encased in a protective fatty bubble known as a lipid nanoparticle [cite: 19, 20]. 

Once injected, this lipid nanoparticle merges with the muscle cells in the arm and deposits the mRNA blueprint inside the cellular cytoplasm [cite: 19, 20]. Crucially, this blueprint is structurally incapable of entering the cell's nucleus, meaning it cannot alter or integrate into human DNA [cite: 19, 20]. The cell's own native manufacturing machinery (ribosomes) reads the genetic instructions on the mRNA and temporarily constructs a harmless, standalone fragment of the virus—specifically, the prefusion spike glycoprotein found on the surface of SARS-CoV-2 [cite: 19, 20]. 

The host cell then displays this newly synthesized spike protein on its surface [cite: 20]. The immune security force observes this foreign protein, recognizes it as a severe threat, and undergoes rapid training to produce highly specific antibodies against it [cite: 19, 20]. Once the spike proteins are built, the body quickly degrades and discards the mRNA blueprint, leaving behind only the robust immunological memory required to fight off the actual virus if a natural exposure occurs [cite: 19, 20]. This cell-independent manufacturing process eliminates the risk of live viral contamination, dramatically accelerates production scalability, and notably sidesteps the risk of self-attacking autoantibodies that natural viral infections frequently trigger [cite: 20, 21].



## Was the Smallpox Vaccine Perfect? Correcting Historical Efficacy Misconceptions

A prevalent narrative in contemporary public discourse is the assumption that the smallpox vaccine was an "all-or-nothing" miracle—a perfect biological shield offering complete, 100% protective efficacy [cite: 22]. This retrospective romanticization often serves as an historical proof-of-concept for eliminating other pathogens, but modern epidemiological review suggests a far more nuanced reality. The eradication of smallpox was anything but the result of a "one size fits all" biological campaign [cite: 22]. 

Modern retrospective analyses highlight severe methodological flaws in the historical data used to calculate the vaccine's near-perfect efficacy during the 1960s and 1970s [cite: 22]. During the hot phase of the eradication campaign, researchers conducted ex post, retrospective evaluations of smallpox attacks among contact persons of index cases. In calculating vaccine efficacy, epidemiologists frequently relied on an inaccurate assessment of the "population at risk" (the denominator). Total numbers of contacts were often used, even though viral transmission was highly focal and concentrated in specific overcrowded conditions [cite: 22]. 

Furthermore, historical efficacy calculations systematically failed to integrate significant confounding variables, including age, socioeconomic status, baseline immunity maturation, and dwelling density [cite: 22]. For example, a landmark case-control study conducted in Punjab, Pakistan, reported a 96% vaccine efficacy rate [cite: 22]. However, modern reviews reveal that the study groups were entirely incomparable: the vaccinated cohort consisted almost exclusively of adults with mature immune systems, whereas the unvaccinated cohort was largely composed of vulnerable children [cite: 22]. Similarly, in a major study in Madras, India, when the data was adjusted to account for families with low overall vaccination rates and higher densities of unvaccinated members, the calculated vaccine efficacy plummeted from 97% to a staggering 59% [cite: 22].

These corrections indicate that the smallpox vaccine was, in epidemiological terms, a "leaky vaccine" [cite: 22]. It brilliantly modified infection rates per exposure and reduced morbidity, but it did not provide absolute, impenetrable protection. Consequently, the eradication of smallpox was achieved not because the vaccine was biologically infallible, but because it was deployed in tandem with aggressive, behaviorally enforced quarantine, intense case isolation, and localized containment [cite: 22]. Questioning the vaccine's protective capacity during the 1970s would have been operationally counterproductive, leading officials to ascribe the benefits of behavioral containment entirely to the vaccine [cite: 22]. Understanding this "leaky" reality is vital for modern public health, as it validates the necessity of combining imperfect modern vaccines with non-pharmaceutical interventions.

## Did the Public Welcome the Vaccine? The 19th-Century Anti-Vaccination Leagues

The narrative that nineteenth-century societies uniformly embraced the smallpox vaccine is another profound historical misconception. In reality, the advent of vaccination sparked intense public skepticism, fear, and highly organized political resistance [cite: 18]. Hesitancy to adopt new medical technologies is not a modern phenomenon born of social media algorithms; it began with the first smallpox mandates [cite: 18].

As governments recognized the public health imperative of the vaccine, they began passing laws making smallpox vaccination compulsory, most notably the United Kingdom's mandate in 1853 (which was followed by legislation making variolation illegal in 1862 due to its ongoing risks) [cite: 11, 18]. The response was immediate: robust, highly organized anti-vaccination leagues quickly formed across the UK and the United States, utilizing specific rhetorical arguments and mass-produced pamphlets to oppose public health mandates [cite: 23].

In the United Kingdom, the primary argument mounted by the Anti-Compulsory Vaccination League centered on fundamental civil liberties [cite: 23]. Opponents viewed mandatory vaccination as an aggressive "incursion of the state" into personal choice and an egregious violation of traditional parental rights [cite: 23]. They argued fiercely that the government was "trampling upon the right of parents to protect their children from disease," framing the policy not as a public health measure, but as the tyrannical criminalization of health [cite: 23]. Pamphleteers argued that Parliament had "invaded this liberty by rendering good health a crime, punishable by fine or imprisonment" for non-compliant families [cite: 23]. In the United States, similar socio-philosophical movements took root, decrying the infringement of personal liberty and basing opposition on deep-seated spiritual beliefs regarding holism, natural healing, and environmental purity [cite: 23]. 

To sway public opinion, these 19th-century movements relied heavily on visceral horror imagery and graphic fearmongering [cite: 23]. Because the vaccine was derived from cowpox, widespread rumors circulated that the injection would cause humans to sprout bovine features. More perniciously, anti-vaccination tracts characterized the vaccine as a "mighty and horrible monster" that unleashed diseases from a metaphorical "Pandora's box" [cite: 23]. Activists published claims that vaccination was directly responsible for spreading the plague, syphilis, leprosy, "foetid ulcers," and "filthy running sores" among mankind, particularly targeting innocent infants [cite: 23].

These arguments were widely distributed through a dedicated ecosystem of journals, books, and newsletters, such as the *Anti-Vaccinator* (founded in 1869), the *National Anti-Compulsory Vaccination Reporter* (founded in 1874), the *Vaccination Inquirer* (founded in 1879), and earlier texts like *Vaccinae Vindicia* (1807) [cite: 23]. By the late 19th century, large segments of the public were convinced that the vaccine was neither efficacious nor safe, forcing historical public health officials to combat both a biological pathogen and a virulent strain of ideological misinformation [cite: 23].

## Who Truly Eradicated Smallpox? The Unsung Global Coalition

The final eradication of smallpox is often depicted in institutional histories as a triumph of Western medical ingenuity, heavily crediting figures like Edward Jenner and American epidemiologists at the Centers for Disease Control and Prevention (CDC) [cite: 24, 25, 26]. While their contributions were undeniably monumental, this framing is incomplete. The global victory over smallpox was driven by a vast, unsung coalition of non-Western public health experts, policymakers, and local healthcare workers whose operational innovations and relentless field labor ultimately extinguished the virus [cite: 5, 24, 26].

### The Soviet Catalyst and Cold War Geopolitics
The World Health Organization formally launched the Intensified Smallpox Eradication Programme in 1967, but the political impetus for a globally coordinated campaign originated much earlier—in the Soviet Union. At the 1958 World Health Assembly, Viktor M. Zhdanov, a brilliant academic and the Soviet Deputy Minister of Health, made a bold, trajectory-altering proposal [cite: 5, 16]. He recognized that while smallpox had been largely eliminated in Europe and North America, it remained heavily endemic in fifty-nine countries across Asia, Africa, and South America, threatening 59% of the world's population [cite: 6, 16]. 

Quoting Thomas Jefferson's vision of a world without smallpox, Zhdanov passionately argued that the disease met all biological criteria for eradication and proposed a mandatory global vaccination campaign to be completed in just five years [cite: 5, 8]. This Soviet initiative forced the issue onto the international health agenda. In the complex geopolitical environment of the Cold War, the USSR utilized the WHO as a diplomatic theater to push back against perceived excessive U.S. influence, leveraging global health as a mechanism for international cooperation [cite: 5, 27]. The WHO became a collaborative space where the two superpowers bracketed their nuclear rivalries in pursuit of a shared humanitarian objective [cite: 5, 6]. 

### Strategic Innovations in West Africa and India
When the intensified campaign began, the WHO's initial strategy relied heavily on a standard mass vaccination approach, aiming to vaccinate 80% of target populations to establish herd immunity [cite: 28, 29]. However, field operations quickly revealed that mass vaccination was painfully slow, logistically impossible in highly transient areas, and insufficient to stop outbreaks in densely populated regions [cite: 30].

The pivotal strategic shift—moving from mass vaccination to active "surveillance and containment" (also known as ring vaccination)—was heavily influenced by field experiences in West Africa and India [cite: 15, 29, 30, 31]. In Nigeria and across West and Central Africa, local public health leaders like Dr. G.A. Ademola and Dr. E. Ademola Smith, working alongside international operations officers, innovated rapidly [cite: 31, 32]. Rather than blanketing a country with vaccine, they directed teams of local "runners" who scoured commercial centers and villages for rumors of smallpox cases [cite: 28, 31]. When a case was identified, they immediately isolated the patient and aggressively vaccinated only the close contacts and the immediate geographic circle around the patient, effectively starving the virus of new susceptible hosts [cite: 15, 28, 31].

In India, the sheer scale of the population required an epidemiological army. Indian health officials, led by Dr. J.B. Shrivastav (Director-General of Health Services) and Dr. M.I.D. Sharma (Director of the National Institute of Communicable Diseases), orchestrated an astonishingly complex search network [cite: 31]. They mobilized over 150,000 health workers—ranging from local paramedical assistants serving as cultural interpreters to corporate personnel from Tata Industries—to conduct intensive, six-day monthly searches across millions of homes [cite: 31]. Furthermore, Indian health workers established a highly effective, rigidly enforced quarantine system; "watch guards" were posted outside all doors of an infected household 24 hours a day to physically prevent the disease from spreading, while government stipends were provided to poor families to cover food costs during their quarantine [cite: 31]. At the borders, over 100 checkpoints were established to screen for imported infections from neighboring Bangladesh [cite: 31]. 

### The South American Offensive
Brazil represented the last major stronghold of smallpox in the Americas, complicated by large, remote areas in the Amazon basin that lacked formal health infrastructure [cite: 33, 34]. The success of the campaign in Brazil was spearheaded not merely by international directives, but by local physicians and public health leaders such as Raimundo de Brito (Minister of Health), Oswaldo José da Silva, Cláudio do Amaral Jr., and João Batista Risi Jr. [cite: 35]. These leaders leveraged a period of intense national political restructuring following a 1964 military coup to build a comprehensive national system of epidemiological surveillance [cite: 35, 36]. By engaging young Brazilian epidemiologists and adapting international guidelines to the rugged geography of the country, Brazil interrupted transmission entirely by 1971, allowing the global campaign to shift its remaining resources to Asia and Africa [cite: 16, 34, 35].

### The Last Mile: Somalia and the Horn of Africa
The final, and perhaps most difficult, theater of the eradication war was the Horn of Africa. Nomadic populations, rugged desert terrain, and the outbreak of the Ethiopian-Somali war in 1977 created nightmarish logistical conditions for health workers [cite: 37, 38, 39]. The effort was brilliantly managed at the global level by Dr. Isao Arita, a Japanese virologist who served as the deputy and later head of the WHO Smallpox Eradication Unit [cite: 29, 40]. Dr. Arita championed the surveillance and containment strategy, solved catastrophic vaccine quality control issues by implementing international independent testing, and meticulously archived the programme's data [cite: 29, 40, 41].

On the ground in Somalia, Dr. Abdullahi Deria, the national Smallpox Eradication Programme Manager, orchestrated the final hunt for the virus [cite: 38, 42]. Facing a highly mobile nomadic population that was largely resistant to standard mass vaccination, Dr. Deria implemented a system of intense localized surveillance [cite: 38, 43, 44]. He established a reward system of 200 Somali shillings for reporting new cases and worked closely with local camel herders to track the virus across the desert [cite: 38, 43, 44]. It was this relentless, culturally integrated effort that led to the discovery of the world’s last naturally occurring case of endemic smallpox: a 23-year-old hospital cook named Ali Maow Maalin in Merca, Somalia, in October 1977 [cite: 16, 25, 42, 45]. Maalin survived the infection and later dedicated his life to working as a polio vaccinator in Somalia, embodying the enduring legacy of the eradication campaign [cite: 25, 45]. 

## Why Cannot We Eradicate Everything? Smallpox vs. Modern Pathogens

If a globally coordinated coalition could vanquish smallpox in the 1970s, why do diseases like COVID-19, seasonal influenza, and the reemerging Mpox virus continue to ravage modern populations? The answer lies in the distinct biological and epidemiological traits of the pathogens themselves. 

The strategy of surveillance and containment worked flawlessly for smallpox because the variola virus possesses specific biological vulnerabilities that modern respiratory and zoonotic viruses completely lack [cite: 46, 47]. Modern eradication is rarely a matter of merely lacking political will; it is often a matter of viral biology. 

The following table contrasts the biological traits that made smallpox eradicable against the traits that make modern viral challenges so stubbornly persistent.

| Trait / Characteristic | Smallpox (Variola Virus) | COVID-19 (SARS-CoV-2) / Influenza | Impact on Eradication Efforts |
| :--- | :--- | :--- | :--- |
| **Animal Reservoir** | **None.** Humans are the only natural host for variola major and minor [cite: 5, 48]. | **Yes.** Extensive reservoirs exist in bats, birds, swine, and other wildlife [cite: 49, 50, 51]. | Zoonotic reservoirs mean a virus can endlessly circulate and mutate in animals, periodically spilling over into humans. True global eradication is practically impossible when animal hosts exist [cite: 49, 52]. |
| **Symptom Visibility** | **Highly Visible.** A characteristic, severe pustular rash makes clinical identification straightforward [cite: 1]. | **Variable.** High rates of completely asymptomatic or mildly symptomatic infection [cite: 50, 51]. | Hidden chains of transmission allow COVID-19 and Influenza to spread silently, easily defeating visual surveillance and traditional contact tracing methods. |
| **Infectivity Timing** | **Post-Symptom Onset.** Patients generally become infectious only after fever and the visible rash appear [cite: 1]. | **Pre-Symptom Onset.** Patients can shed high viral loads days before showing any clinical symptoms. | With smallpox, a patient could be identified and isolated *before* infecting large groups. Pre-symptomatic spread makes viral containment a perpetual, failing game of catch-up. |
| **Genetic Stability** | **Stable.** Variola is a double-stranded DNA virus with a relatively low mutation rate [cite: 51, 53]. | **Highly Mutable.** These are single-stranded RNA viruses that mutate rapidly due to poor proofreading enzymes [cite: 51, 53]. | Smallpox vaccines offered decades of reliable, broad protection. High mutation rates in RNA viruses necessitate constant genomic surveillance and annual vaccine updates to chase emerging variants [cite: 51]. |

### The Modern Challenge of Mpox and Zoonotic Uncertainty
The reemergence of Mpox (formerly monkeypox) vividly illustrates these modern epidemiological complexities. Although it is an orthopoxvirus closely related to smallpox, Mpox has a persistent zoonotic reservoir (primarily rodents in Central and West Africa) [cite: 49, 52, 53]. Driven by converging factors such as deforestation, wildlife trade, human urban expansion, and the natural waning of global orthopoxvirus immunity following the cessation of routine smallpox vaccination in 1980, Mpox has fundamentally shifted its behavior [cite: 49, 52]. It has transitioned from causing sporadic, isolated spillovers to fueling sustained, rapid human-to-human transmission networks [cite: 49, 52]. 

Recent epidemiological data from 2024 and 2025 highlight the alarming rise of Clade Ib in the Democratic Republic of the Congo (DRC) and surrounding East African nations [cite: 49, 52, 53]. Genomic surveillance reveals that recent lineages have accumulated an unusually high number of APOBEC3-associated mutations, an evolutionary signature aligning with sustained human-to-human transmission [cite: 53]. This highly transmissible and potentially more severe variant has driven the WHO to declare Mpox an international public health emergency, with over 100,000 cases reported globally across 127 nations [cite: 49, 52, 53]. 

Fortunately, historical smallpox vaccines provide significant cross-protection. Recent studies indicate that first- and second-generation smallpox vaccines (like Dryvax and ACAM2000) remain approximately 72% to 75% effective at preventing Mpox infection even a median of 13 years after administration [cite: 54, 55, 56]. Despite this immunological advantage, the logistical reality of deploying newer vaccines (such as JYNNEOS) effectively in resource-poor, conflict-ridden settings remains a daunting operational challenge, underscoring the enduring complexity of global health security [cite: 49, 57, 58]. 

## What Are the Practical Takeaways for Future Pandemics? Community Trust and Last-Mile Logistics

The history of smallpox eradication is not merely an archival triumph relegated to the mid-twentieth century; it serves as a highly relevant, living blueprint for managing modern global health crises. As contemporary public health officials grapple with the staggering logistics of deploying mRNA vaccines, mitigating resurgent Mpox outbreaks, and preparing for the inevitable next pandemic, two critical practical takeaways from the 1970s campaign stand paramount: the absolute necessity of community trust and the operational mastery of last-mile logistics.

### Trust Over Authority
Dr. Bill Foege, former Chief of the Smallpox Eradication Program and later CDC Director, poignantly reflected that the cornerstone of global disease eradication was "not more authority but more trust" [cite: 7]. Top-down bureaucratic mandates rarely succeed in isolation. In India, aggressive attempts to force vaccinations on resistant populations initially failed; true progress occurred only when public health workers embedded themselves in the local culture, respected indigenous customs, and utilized familiar paramedical workers to bridge the divide between foreign epidemiologists and local families [cite: 7, 31]. In Somalia, the tracking of the final, elusive smallpox cases was entirely dependent on the willing cooperation of nomadic camel herders, who mapped the deep desert routes better than any imported WHO expert could [cite: 43, 44]. 

Today, as vaccine hesitancy, rampant misinformation, and intense political polarization severely hinder the global response to pathogens like SARS-CoV-2, the smallpox experience proves that public health is an exercise in sociology as much as it is in biology [cite: 8, 18]. Interventions must be collaboratively co-designed with community leaders, and risk communication must prioritize transparency, equity, and cultural humility over unilateral state mandates [cite: 57, 59].

### The Mastery of Last-Mile Logistics
The most brilliantly engineered vaccine in the world—whether a live-attenuated virus or a synthetic mRNA blueprint—is entirely useless if it cannot survive the physical journey from a laboratory freezer to a patient's arm in a remote or conflict-affected village [cite: 57, 60, 61]. The smallpox campaign revolutionized "last-mile" logistics through deliberate technological innovation. The development of heat-stable, freeze-dried vaccine formulations eliminated the reliance on fragile cold chains [cite: 28]. Furthermore, the invention of the bifurcated needle—a simple, easily sterilizable tool that captured precisely one drop of vaccine between two prongs—drastically stretched limited vaccine supplies, guaranteed a 95% take rate, and required only minutes of training for lay volunteers to master [cite: 15, 16, 28, 62]. 

Modern immunization campaigns face even steeper logistical hurdles [cite: 63]. Current advanced vaccines, such as those for Ebola (Ervebo) and modern mRNA COVID-19 vaccines, frequently require strict ultracold chain storage (often between -60°C to -80°C), making rapid deployment in fragile, resource-poor humanitarian settings incredibly difficult [cite: 57, 61, 64]. The legacy of smallpox eradication demands that global health entities continually invest in physical infrastructure, support the development of next-generation temperature-stable vaccine formulations, and expand local health workforce capacity [cite: 57, 61]. The integration of Equipment Monitoring Systems (EMS) to track real-time cold chain performance is a step forward, but as demonstrated by the ongoing, arduous efforts to eradicate polio and control Mpox in the DRC, overcoming geographical barriers to deliver medical countermeasures remains the fundamental operational prerequisite for ending any pandemic [cite: 61, 63, 65, 66].

## The Bottom Line

The eradication of smallpox remains the singular instance in which humanity has permanently wiped a pathogenic viral scourge from the face of the earth [cite: 1, 6, 15]. This monumental victory was not achieved by a monolithic Western medical establishment waving a perfect biological magic bullet, but by a profoundly diverse, decentralized, and highly adaptable global coalition [cite: 5, 6]. By expanding the historical lens, it is evident that the early foundations of immunology were laid by indigenous practitioners utilizing variolation across Africa, Asia, and the Middle East [cite: 10, 14]. Furthermore, the sophisticated operational strategy of surveillance and containment that ultimately cornered the virus was forged in the field by dedicated local health leaders and unsung workers in India, Brazil, Nigeria, and Somalia [cite: 28, 31, 35, 38]. 

The transition from the physical "training dummies" of early live-virus vaccines to the highly sophisticated "secure blueprints" of modern mRNA technology represents a staggering scientific leap in our ability to train the human immune system [cite: 2, 17, 19]. Yet, as the persistent, evolving threats of COVID-19, influenza, and Mpox continuously demonstrate, advanced biology is only half the battle [cite: 8, 53]. 

The enduring, practical lesson of the smallpox eradication campaign is that brilliant science must be inextricably married to cultural empathy and operational genius. To survive and suppress modern outbreaks, the global community must remember that pathogens mercilessly exploit the logistical cracks in our infrastructure and the ideological divisions in our societies. True pandemic resilience requires unyielding political commitment, the logistical capacity to reach the furthest miles of the globe, and the fundamental, unwavering recognition that in the interconnected realm of infectious disease, no one is truly safe until everyone is safe [cite: 45, 60, 61].

**Sources:**
1. [who.int](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFNmd8lC8orZIp0cxYQhH9Q5344nJr6fc72YCYITCguwWAOx7mBBy6KmwKD6nZRfwYXvqdyYqYwkSn3f2okcskG16kDNYfUGEGZYcNmkFO5mlb899XXBkzD6QlMY3BuDPE=)
2. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGZGY-VbmxpKynyAZcbw_R39WpXAmBeaIqgy-c8azs1ihy9nis3uBIBG6EdETRsKyvGbdSaDOZA3pFK1U6Cp__A9PQ5euUU6WvaicdOxgIW_w49Ml-SE-FJWMPFjxfw2-5rn_F1y2w3)
3. [notevenpast.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF369rooiiFi5p3q1npDOIztCwLJvco-7PPFH6wYWFvO8WskbyCkl8LvyzFlIWgnc7PB8R70udxxqJ4yLpEVvMxWW8crzRv-FdSsuuTtPmf2jkIhi81y_JiuWdrIqAKIrhJPZ_Hcvi6aiyvJLtUKRHsrQ==)
4. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGYjIoc5-RjH6CFC0dxyURDtMx5L15nFSiMj_c24uLQcTokXj7DMWv--qRx5ktlSk5SbB92Yi-9H17fx0JVDFoHqOC3UEFWNKlvD1AFajB0ghd5bibrKDwXVdjAd8MqzY2Yl_nfoEQ-m3JpD13X6fjMQg==)
5. [csis.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHRhM0xpbVO2uYBYI1e_5IJ4nopJ6PTAcJ-SF8vqrj2mbldOEDmiUNwfWE3O_g2F0qghFsiYJuQm8OuQVhbCsFJOez0_ogSoovkZvvns1sRxxT7dEBZZSEI1vjqo3Xxv1BiAnM3ueqwfaS4snDvDq-uCdmmhIib3aFS1cmdy9AXQFc=)
6. [northeastern.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG9x2jE6jWyxTivaKlSojZe8fsRv1vBLW2a5s3fjtot6HmLP5AULAAdLMJ6adaALSTP7zMC0UK168InGV4QADiNqVUD1eJ7hgr8lFI6GKgcHi7knDBuOSr6dw3b7B-aObZ2YjQ5E0DgTlukGaqJVkcSh4ZrlYZpeDGiub8MUyz-MMmBQkDMLlXdj5QOVxs-4ZQb8KUELY9QFoFEdVqon-9aVzE6K0w4M7I8tqc5DEpEoweQOCP_Md5tkW5Lixu-prgTZQZ74BIi5779VNbi-X170LjZc6g7W8khwdpD)
7. [yale.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6MXKiQEfl6l9geWhQxoUYFO1eJlw7K_j3ZFwljeGBmmgOtM_ALKj5Pi_3E9AC8-RnQ5zdf1sSExI8h2finOKEANXaRUSj_k8tauf9R88MrCfCQEZ7nQWUa3hkYK96j_zoHV_W-erH8j2O9AMa9fYYftfwC2hK1xIKj3RBtN3zKFDNmUj0xT1AB0OX1d-DsN2qMug=)
8. [time.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWbxBdVs5OHQzwHNyen6nPhlkK-yrgasXjttepPevEaBw7TD3ZS04c4Wo5unKSF_5sSr6DWdpO90ZSPXzVRkJ6fSLXaqFP_44ZeH8b66ddyurbkFvW8igtwRQPut0vU6aJsqagYM7ySoNOjY0R3ofTIo2XByBhjdtsTR8=)
9. [pbs.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG6STjKo5C_u7cTsYE4aFrGqKdbs0I4hf08J-1fc_FSBdA6wEtV8zalHIJGd05245VyOuVQfAAe4GayUrKRYBY8v9wwi-7OccfNTgoRU3YdMPboHZpSVrvcpWSIva2ZD4WXzVPdTY3NJ0Bgi31Fx_r1cOh5sg52GCDOkon3KKovMZdmDYUbxIyR7YowK-W1AaLy)
10. [hekint.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGL771BVD1XCWsjQb3yZYHGm-oVtLUtlUoLx5AFMw1_tb4mdJFDm5DQijF5XCwV5hBG5i4St4JiLHLygcrn-Kr2jHQB5mCyefHG38henEooU9YQpZ-t__YaS5ztUczGoFil6Ye1NLcuQz4yEpelHxjziSni80pD)
11. [uvic.ca](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHFtgNIlApDeDchj2crIPYlBrQTCPz3gHYQ5xsA_ptGEPoXZ2nUJH2tWQqutT7F2-tPElYJTOuiexotAfrNgDyGdiQHwcgz7P_asoLlfcgw3QuS-lVrKGOULEti)
12. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGY1lam4-6EQNXcZKuW5KdejO5xMQodBN4Z3IPoCAQQOLz3okLKoVwd4JzeppqvQ7ycMCGMDlD1fsjLUm55BAILyvELjWCBf9MY6xjNRvTF7M30NNdTzuXnMSA8tISP8QCtY_BZAQ80ddn9p5u2hfGJCvc9NUfPfV5WC1oe8yR7l38lGS2qi2b0ekgN6tT_FM9fNc7jT-bUzgDi-R2hI7jO11zBxInElyB7iVl3jRvXl0Pd1KounrC5VaA0KTJMRpd3FPNeNZgLzi9tHFNSpOEH_6xS9WWhGk3EIATESZwtLFbXJQHP8TB_pBdddQ==)
13. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH0EyfZeLoLU8nO1j-5xiJyquXD8QgdoarJXQwpgQcbDyu_Kom3Nnr7FFetgi5-HO-wO2wvADAsrloMSoasf0PZK24IwRzA3ZNYswihHpuhB_IFtCKnMF-0sz1ZKA0Vmw==)
14. [Link](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEjM4KvU9i0ZDgxZL-IJbqi-wRAGMiko_10pXB_KVNxJpjGkv75S7t-lVfLHWu-4z0rCFEYFry3c6Pd1klOOoPzYfT08Ij1dBYGaTMhhpZea2QHBl3zrgchstPX5cAxKkSdNcPf0W0y)
15. [nfid.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2iT7NvaJJLAEKcR8R4KexuI8KLt0_i8JauLoc0PaH_sGbfV_4Q5otSAFpn47PZbt42Eb7iCBsRA4LJ_iN4uUXbaJn_jVUGHEudMWzBwS5VQ_9-qXwevL7XxTgdVmwWPzhTwe3-3yC3LliSHWTAbO6nGZ4ZqVWI8IUwVOS4YLPm4VgG1DDphe5iuL6OkEbgw==)
16. [ebsco.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHGHLvo0l3LagU5hplClcsHvbbqj-72rRezZgUZQS5XE2cKYr6sS-coglPvnYW7C-N2bbyEg0JYMtkA3uzdZpLX5mwp72W8Kdg8lOmPLxWRQpm74cj6JtMHR9YjhJS3S0TTX44WkQLoTh2vNgnsS-YOzKBP7wlMBgUqq-BV-O3phhSRFPjTABISLvBzcd3BcH8z47MTiMPLGt1a4idase54kkP-SKoltZ-TVhGLo6Q=)
17. [substack.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFvpN1B-3yFajQQWvJ9OcVjIJEZUVzzzTPPs5K-G7yLQbPQWvc8lilz8-WRsjVYN453QXNCnffhtccuZTo9NMdPBc2J2etRC0uARi0XDRdgLte1I2YDdvL_KTAG0kzChCoO4gPoVBczcFI3yuvqDMk5OUFykKtpd5F72ZBKr17m_w==)
18. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWmwNnS0oWZLPDmkaO89gE9LuV3HUhqKHd2Q2VO88PRFQIDroG5Y4caqb-VTDoKO9JL61okqkZSggqc4sDc1ne3NvDg1dN9tOpprQwKafxhHNnwi62_kfyxuxKkjCrldqRFQ1BVbB5fA==)
19. [youtube.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFZdPfZFuYxhA9_PzOc2jbCmk85ICIxf5lsj8fzRd9Bf6jfpFtWC6d40vb4Evw2rYDK7VDZQb6aueSuzNdLLYgYjubfXbztQcGwezqsGWfM1YVa9agei_Bs6Py_t7fmB2Q7)
20. [vumc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQECwnETB7Qrtf1rG2iTNG5ny1VluyWdUG3WhdQrya3cWyhNGOwA4a1OcuGP6aqNbuHa4r-WTPP39n4CY-rJLxonbZTvIJyxswuCboQZzkN3ae8vC5O-ibJ7rarjOMX5sjc_kp4Ibb3ft2n-LxY2B7bp9wCS5MhBr-zG2bp3_delF6G1yoR5x1DMZ2IpKO5nPw==)
21. [yale.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEs2BBefVb0KZ2rQuzoE5vtAu56NTE42iEBW3RNBrItYhriZKHQmhPaVwL2dqJWCVLY0HQffTtg0PpNcv5AFPLNNASx2OA4rsrPPPmGaiiclnuk_Nk2SGo9zyZiLmuJpFLg-VMqWO50d1Tb0OxujdcstjkF-FwvHExU-h_3ZWeN0rhz04IzNM9JXT8dAxlYfWeOrepXYBK4FWQqUsFjFrfxM3Ws2CBgXNR77eII)
22. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF7vYYSekmh_nORlYW-Uri0XIPrf7VsPmUairoa2R3nqg0Uvgr9_-2tTrJNsO5HoL45VpOdc8T5cf29Af_ofw5xjCWFY0khbILLDK1N5_0HkiYOWfKfXn9QMehVfAEC4I5jmS9yc7QV)
23. [Link](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG78fMEsDKbZ1C4pLMJgIeUmYbhWAMti6KyRM4RimrYSKmL-rRhAnsUq0z8tm3CmA4GTw5BmwT-AeKo0CUwkduvjh6ZHitQxLyvegZh3j3ysEnGNU_Qw3ogOtA9vdSHjJjP3GFh80vP)
24. [bmj.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8rJ7Iz3GAKE6TgqsodS6LFBZi-WF-5gLCeTBgeRd4Zun3Jz1NcsO3SWlyotGvnYLT7fSiC0ypkrXSmD4d17cMwvxO8zuoHbTz2KAz02glIeC_hFPtaXWZpaOt0Q==)
25. [cdc.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHoVpA2dfCHuoa-PtJrrDkoIOCTGlI8nMH7Hm3R9r6daXWuKSHP9q-rYPY_-CU09QQwzCkHJ798h4Q9cA-jv1dTZ1xL24_reuylVazTwaqwUIV0gDDpoVp4w2O3EsNadjxOc98Iug2h-OfG3YqiejkYh9HPxmiKOtBAiXAUNUm6P5fSXbLzvBiH8w==)
26. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHzQlDtMDhdlUcyz-oDwFxRK0ev05SKZrn3EugXNf21R89PsOuyVuklOOEOfQByusSY1oowXolltbuc9RtYBM6_0pI4rUSehMeJWwtJ8-igvqOLi0FPuys8cQvCnTXD2eyZTUwaxvf5)
27. [zero-pox.info](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH145ciOBbFi-BD6kie603aEFuZ4m5kSv7O34QMTiGDdVvJPXpOqpfQTAtd4Dm3XctQUW1xotpbeGu2-tcLBO72QtNANRqtBbbxMBSbXXFQ4fr-23HGvjwQq0yzi4XLUNxFviHEfw-Zug==)
28. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHIz9TfWDXW5LQTvN5cxWRJNkxr__f7onGxV5dWyT11VhOiBgcjUhTxmxVLQwiEgDPz28diLRdSPMUlEAk3Uu2pnRWUZZ4zlzwYjITQ8YhObJ13nU6vYtTNX_ypYJu_ihybm4pRBrIL)
29. [wikipedia.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHViKaZ5-yCzwxAYe6MTorQE1l9lF0aJRBBGS60K4ForydNrv8rgDBQgCJ26QCb7Sd45qirBL_7dalVIKeNZKegPnbOSC-NntZ_SdfMcKgKUcRcptfIvI43PSI-F56F)
30. [who.int](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEGHMRYNluGaUPKmT5oCEcpmupKaRKBjvMNjchVIcyLajq2NeK62e4lyevUy0FAvYT7vRVEeKi5aIbd0dVrUufHbSXiRx6JLKNdzHBPwciiWV9b1b3lGvpzPPftP5QReYOhNT42XtescR4XZcC_MdgbybFtqqUmpQ7ellJtKnloadUuFBZWNyHCZac3JrmnkY-JK2Qv-knDxdRbgyZqLcE=)
31. [Link](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGVWiQyvFEuKKOQZmE5A4tNnC8o_WQtKTbvf3zLx6hiXSiZrIZmkzKY4JE1FEb0UM-KtvD6qqIlp1faJ4JkPw4JqduPoFoN5IX-7qiAS1NvGN0Bm8RvZYjDsmoRZjx6NPMdYTjVmqhjbXkJqNCEHf9dznePnPbwDB9SZWzI4DolQ9y__M-HJA==)
32. [globalhealthchronicles.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGNqwL-kl9-ubV_DdBoKJz0MXYxPjGBnL6z9DRAz80yp_ErJhZ_AGmpn6w07DNUQ0zJUakeMFw_wxl2ZAFs1QoMbDTYMW_cUHE8z6us1eTpWzfc3u7Py2yJi7Phqd4tQdaRCBr57xT7qqKLRg==)
33. [zero-pox.info](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH41xXjmiE_w0klFpP-6QTxrF86bPj4XlbgX_Wljk5cI7-rJ9vA3cE2MLJfImQkOjPbRVooesKSEkVvzHbNqoeFxKdDMd5BUDueXXljkSPVYvvjMfx4cnNtiuac)
34. [lsu.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEFjjf0hHtaWhA-S12oMcZd6T5IOqW7tdB2iNVxayA487FYVrYRq1G51vuZwptu01HoYexNd4_KX9bcjhhizlAi_Ulv2GYjZ_leKZ4XffuQuiIIZ0OIRnE7BCVyeDUbzrUnRGisBgv6B5_wbds8n13k9kqJxEIyVu857qIn)
35. [Link](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGllt3owbr0eE-HmOGoEWPD5E_DdLi1Xh-g4cHn2zWSec95Iy_ufeLEODJCinvdA_SAC0GJvzrLP66NLYz2mqmTE7_DBr_xFBUV5Y-tvKSJmAGMvea84zjGk6Ch4Zq30pmPPGWeS73c)
36. [cambridge.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGHkhMyB9MfhEdGfttfQ0bCiw6v3U7Ya0VAwYM30f5yseWdesmgRwLpKdkrAaKG6qfEpIPzf1vJmN1qnP0hrfeFAHsSaT7dFnwJdLebM3X-Cr06EcaIUm6IQMvKQiSTzcVAzo_LSPVlwmV4_mW0OyYoQtqSbgpSmWyy6pG4bP6hbp9avhapQRkn5udy1Taor2WwqViE-QkLYalTaLJ5GsrZ8BKePQK8aLf__9ZoZlzm7681vIDwApClc59vke9nAA4JUvDHKw_rJxAImKxhRHPWvqI0zb8Sg8YD25qHFwzq65GI0-XnbmyMe7BGkA2qDy7VmiOw0OItexZwX6zJMurievFI-qPArx8F2Eb6nnPaWL7i65lfhAMSfB33W1XcYA==)
37. [peacecorpsconnect.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHYt8qC7KQxxnTOgpeu69gkPDyy9nnTWbWeHhCgKbBSOSdAhqSssIlAjwjBeWiueeoSqLr0bsajgK5M3tWLBW3iev1ciEN6sAsvuWBYOQa0zF6jG5Vl4KZ0eS-_tKix4MwbylENjiUcbNswR3uT2LQbGWpzZ8v0vrJa)
38. [smallpoxbook.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEqL5Gye6j3Izn6YIhFK5NuRARzQN9XsuCpj7cNh3fCWMGjn3Ydb3gHLv-RfkWVM4rDuBIwlMNlUIpRTxQ41qMEov0FxiWOp6Pfe5PaINBBk9yPKDlH9rlp3eL8M6mW7CPxUnt6TPg2b0DiudC6MeY=)
39. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGHX527YbeUxBsuOPp7ooYtaGTeVHESrR_1wINP5YuzXyMNSfvxzIckTNPOscPfuM77Yz1GW_J1O6OJkvmxqMPbK0S8nPp1F21s-vrO2VKhx1wxPYt9w8fUox4ReJw5Vg==)
40. [japanprize.jp](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfZmOxlYrFlk9ikd-ZBv4wCWANT-CBu9Jti8ykjDbJJBrbApVO1kajlcEXtT_pi0RmgLN1LuAg3Gq6duhh7KLy5l7_L6eyK-TMd9iZqbE7IyJz-vlh94IDT56zFrhM5hk0c_-WDKjPvFSuuk3ppEY=)
41. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvYvR4daSRDh0OTXxXMkLapFrBiDe5BnHZRwv3ONIHdIMzh-Imvna3P2BM1dCHEvEyWyxKrwV4cplUOkW2xZ3-Ax2gd4y9qQavegFoQI4ZBGArcHrlmj4RRhVLEcO97Q==)
42. [who.int](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHEorJgag-mmGYEOKBwvmaKU78UJNLhh0Vtg0nnKwyYSsl_o5h26HSYcayEk98XfWqzJ92Fvv90f-63Dp8qsZkb0Di53w8SbKuvo4ciC_cVZ0XZKzdB9PUZossoRPE2VukLRRVSv2FVOpR09icmR0bEI6jgrs8rTDokjTUi5ctT5k8AhA==)
43. [diva-portal.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHZq6Z1klvfLY05sTFoxuHHlSH9jvveMVR6YtFTpt-5JblhJD0b0NMtvCdfYD5v8xpTr1fPkQ4GP29Z3J-rk0JjBWrWPR1p4BjtiaI7PPBdZt0xUHdixdCRSFPoew5ATuhiy20gP5ByV9aMqbTapI24BV7a349fr5Y=)
44. [umu.se](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFdd15__D49Q1_7HZLHkkI194N6i5KnyoINOt2sTEI20W511p-kOWGxhYE1pVlg53b6Rbl3AZH2hJaEbyGpOtUZcMXVKE_RqV_kqlmL66hDNiq3dsPo94DP82-1be0gYUJpmBe-as0C-qwsFjud8TXHvw==)
45. [gavi.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGTNNBSVrCHtfrQKtTC8e2GughZ6_oVAZiLrb9KV5NquXHAbue2dW6LqXBp50fvviHCysnLW9xLNZ7259Xzyezii7eJkeU1evh0_7rf3ZZi7Xun1E6k8CT16LIWbXQ_MtqLG8EfqTOmBMQ1e08MAldFSc6aMD3F0qzvyCpe4CB_tRagMOFSpf3tMdYNxm8=)
46. [australiawidefirstaid.com.au](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEa_6xbzuKxH2NuTfe5jQmGdkaA-AXvdKuPn6mG77n5FL_CxinyIGhiahU1nPTVzlkf8sEOYyBSz732Qtp4QZw1hMzWd0zHRY1veDuh6jgLHZ6Oxc1bfAgQL7Za0Z-soIPEFkbJHdUZU2eG3Nbq-WUR635J_5-oXpNo8b-cqJP7lX-ZgNQBLPL2Nw==)
47. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGyH51vOkyjyfqfdRpG1mzPtUUpuTZoo9mSYwkTCCtAiHlW00HGGBFG4js1XHg_QoumsTS_NjiLqE4abUhy6j1-Zq9GmKOdemC0FPdbP37a3kbG6lWmjRibF7jw1kSicEkRQPMi1qUU)
48. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFOgyLiS8aoOtiuX6n-_OnX871Lyy_5UDA6520YE5NliFczXogLyB6-S4g5HCTJEwYJbi3_DN0BMT-Hg-Yhqtp-Cs-hHpDJ-G7ZjZjCjY-4mO8FzkZjEsP5GgI_plGF0omCee4RV5Z3)
49. [tandfonline.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGiYswjrXdpJFUEUjH7BFVYZWVD0lC6yz05TSs2SyWPiPyhur1S5HjGH2nl3QjdeDZAAHkQ9WnPltsWA1si4aZwzI_ZidnuMoqQKXnQCZf_tdXFHvM7r7XTZPOln8Sn__FZLu1hzvKxONp5z2iizQ0maPGlEQu3RrI=)
50. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEjem0D1UIa6Q8RmSZQHfo5SZ1FuRZQH9Nlh0BRwQy-sJiAW6zTU2ghkJhmCnjN4R8y2x65bHw7OkZTTzQYuj3fvjoAa2LoNx2phQLHqJFLPqKeO_ppnyaULgf2QOsaV2EQR8c8X9he)
51. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEErbAluNYbcKlBVQwZh4w4QRdQyrYk_xgYxv1Hfc-bH88Mh1NG1XevDoyRyPZW669WvIgYYZtmyMotwhTk_iNCxQ4Jlw3z9nlAsYYCTg5iVCdu0AOEa-BVw7AVf1Zzi_h76cUsRIeQ)
52. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGnTJ6gCqarWRBPKK_c1EcAm7kXtEozafydUeMJBAu1pn7O3-qZldmpH8LJhgfC12VcVTOiooQu96HBgNb21kAvfnad6hljB4Jz67mbDmt3DWHNYgcDO5qCKL4QRkd4QrUFqrnaNmL9Ow==)
53. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGKRIGWlKawFAAbTRJPWh4ripgtmx2HQ2dHfSvzEFba4Vg7WqIVuRZUoe9BsjKEPvxW3qw0WtXcilz34UrALQlqhdpN48NnD-KAbXXFLUaZnfQXXAH0zNIX3XKnkyT6LdqWOxlS9iwlrw==)
54. [umn.edu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH40PpgVgUaHnzkczrLHiBP1UwSwOTtmSeW0gCoXTpTl8m6DNY__fvaUyBVxR1PROxQs1MlxC_aH2n4L0snNxKPkEv_PQqxu021bvOPpEJ5WA0c0Z-tI9UF2jh-A-o1QCbDl7_GIfxiNVUsuxhTkgwFmyrj8lnZQb-tP2Opfv8bMAuCtkMxx1W70JrG67fg0o5VLvxRQJFOimgnzg==)
55. [id-ea.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFyIcUdpOyfj3fPIukc9AJp-GsTS8FZc0iTqgouVnxofrHe8q7nTBA6mNZq2HE76kBF0LS8H0JVlb_IaEFVJp4RfUQWvffeFwSuxNZLfEaiabN1KUfYBXZ3RxAcyvgw03VhGpuGRHzqqduieMzRxdkN7y-5wq6yLXsxalNawZJx63kDG1fy5O7i34Ix_YtHhuOdSCau2yrlQQ==)
56. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHgGmM2SD96VOr_8eQKejDpHETRHYc6UkzOsLlfDkJJZEqMBdV6o_muKOJRF2IYDyY7SDdciGtPzAqeRjy6dXdrEjXuJ_32GlAqw-0pIIPiKm-2MYErLe5TbDlBWlSGf2g4DqjEWBug)
57. [intechopen.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHKX7hq8lmJXefgGocR-SRCYMHarB9DmsxoSqDJvBW_CbC0g6x_El8-qGuETOT_syeJqtk7tCzpZ-zPKvCKip6eKMfUD1vfgeTbMO-xTrQjdZj5kIicrICXfEiJG8HYA5H1jo3vgg==)
58. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHxubz2VmzaRod8wUDw95Hk8okPph_r9WO1dd4pfD_Co7DVVDba8KM938ADBNvgT7m_AGit8DisckozTgnH6xoHEZ-snWi-1Y7-vhv10FHLN0KgZtrJdBPPSMVxZ1_0u8VsYG8rFwaSPCNxXFya1TUrBIuoAub4DN_fPXCpcFXQeHywFzL9JzBN40ho3o69fHYCTcGJGmvHiSNNyTWkRr_ZflPF93jvgSi4m5GxoKwwmESilhzESMdiLnWFNUfMkFmzzgfYjjqssIkc3S1SsYi7q8e7W5HuetNk181d)
59. [unicef.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFXW0mC7nOZ5IExLz4L1gjO0Lget9hnNSCgPuf69w055T7KP6yJiM7PuwNVA3f4T8bgGD2-2DlpaOHaRx6FRYGqZEXcTMjiS-YTKyI6DyZK-gK1UYig6Nk7t2DhkiH5JE7yAPsuJ9_RABp5TXUP4waKfjlVWsN9Bt1BANIC9oviVQfTinDkqfgMjkV25gYqc6lV)
60. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEMcZfSlNosTNZAfYQPFjldVlLvWtSkHuB0kznKnKWou0As8At70BMlCHRTwM4RqxGQAN6fYNkdRkIRJYz0GhyHe34ZegMeCVuHuoqJF8mzQzFLkz_NFSKVFgt1zewjlYu4r0W-MxBs)
61. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE4mou6ssSbhV2v1QglQf4Aex5sPCIDYwoxtjJDbi_CVq8BQhMZJrQoGRekB9DoZBisH3l3GpDoudgeygVn5uakcq5ZN20bjRkn8JTNlVp69nKnOW7w9iOGRsfJZOJgE8aCXgxcZ915Iw==)
62. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQELwSvwAGdpM6Ga0tBaaispwzaE9Y6NRsUy104vXq7slDEHl1vmF3O5NWTpfIEBD5CCbkDLsMiTxNWg8rrpJ8-J4kM0o_grG2n8NcA4gpjrh65nazG6K3ycRbDXw09cAjtV02LPJHkqQyQFy_3EclRYniwknOT1n3lhop9mgEW1iQWRC1O0iOhZTNT5PIi3uptD4csbvRAsL3kfIItBWhWRdYxhBVpSF13jnn2gV8qlk5Y=)
63. [tandfonline.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFvTT6owJCDZgkwpB8IMSY774OQVXAFv6R8oIdJuiwI2zu6ZDX7dBo0wnB8yAvtSZ5yj9jljPRDYQsSfKjHYAS0zEdjuyafA2fGee7pa5S0j2HmgMNjZ9O7IfEUbKUa9XTefdSHNuj58jzw3y-At6Pu7gIzFJ_Zu74=)
64. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEMNE0nnDqz_y7tVvom2B00iCjbTjig1OzO9ZtTyGWrv4CJgyV_b_B1tnuoOsPB-Ej3-qfH6-bCBlWaSh183TzwQ1BIkfigfJr51hoyRe3azJlta4ubhX4Hw1CLf_cv_qOoyU-QrPN2hA==)
65. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHVQJAFW-2mlHzvQ0dFStjf3vUeyr5Z0oXUMBRLO_VTp7MjjaXhqHDoTdvYSo1rgfGSET20CTt92uooHGmQxBaTJvE9PCipgjWeC70Bhen-nYSWmkNtwRUPdhaj63q54f1dS6VPRf8f)
66. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHKuorMSvW57OL7x9wTjmCbMZzTlC4PUS5CVKEjMLVeHXBPCh24lELq4zp6yfE-MD_nnNEJ-zbWTGV1tlhxFExk05uan4GTLKntzCd-jQVSsHI98EUcloePmG3wmFs=)